United Therapeutics UTHR reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
United Therapeutics their estimated earnings by 15.88%, reporting an EPS of $4.16 versus an estimate of $3.59, which surprised analysts.
Revenue was up $64,600,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.07, which was followed by a 0.33% drop in the share price the next day.
Here's a look at United Therapeutics's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 3.02 | 2.94 | 3.14 | 2.78 |
EPS Actual | 4.09 | 3.49 | 3.31 | 3.88 |
Revenue Estimate | 378.75M | 368.95M | 361.07M | 356.95M |
Revenue Actual | 446.50M | 379.10M | 384.90M | 380.10M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.